Found 356 matching trials
Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies? NA Hepatitis B virus (HBV) infection is a challenging health problem. Accordin...
Show More Location
Sherief Abd-Elsalam
Learn More & Join Trial
The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg PHASE4 HBeAg-negative chronic hepatitis B (CHB) patients with low Level HBsAg were...
Show More Location
Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University
Learn More & Join Trial
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B N/A This is a prospective, multicentre observational study of Chronic Hepatitis...
Show More Learn More & Join Trial
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants PHASE2 The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Show More Location
RDSS Research Center
Learn More & Join Trial
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B EARLY_PHASE1 Previous studies have shown that there are alterations in the number and af...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Disease Loads and Status of Treatment N/A The aim of study is to evaluate the current prevalence of HDV infection, an...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321 PHASE1 This is a single centre, three single administrations (Days 1, 29 and 57) a...
Show More Learn More & Join Trial
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus N/A 296 million people worldwide are infected with the hepatitis B virus (HBV),...
Show More Location
Hôpital Saint Louis AP-HP
Learn More & Join Trial
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection PHASE2 NAPs have been previously shown to clear serum hepatitis B virus surface an...
Show More Location
Infectious Clinical Hospital (n.a. Toma Ciorba) Department 5
Learn More & Join Trial
Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine PHASE4 In this study, subjects who received primary neonatal vaccination with hepa...
Show More Location
GSK Investigational Site
Learn More & Join Trial